CVS Sues Arkansas Over Law Banning PBM Ownership Of Pharmacies

CVS Health is suing the state of Arkansas over Act 624, a new law that prohibits Pharmacy Benefit Managers (PBMs) from owning and operating pharmacies within the state, which CVS claims will force the closure of all 23 of its Arkansas locations. CVS argues the law, which is the first of its kind in the U.S., is unconstitutional, violates equal protection rights, and will limit patient access to medications while increasing costs, while Governor Sanders contends it curbs abusive practices by PBMs; the outcome of the suit could have significant implications for the vertically integrated healthcare business model and access to pharmacy services in rural states.

Analysis

CVS Health has initiated legal action against the state of Arkansas to block Act 624, a newly enacted law prohibiting Pharmacy Benefit Managers (PBMs) from owning and operating pharmacies within the state. CVS, which operates the PBM Caremark, the insurer Aetna, and is the nation's largest retail pharmacy operator, contends this legislation will compel the closure of all its 23 Arkansas drugstores, leading to significant job losses and increased healthcare costs for Arkansans. The company argues Act 624 is unconstitutional, citing violations of the U.S. Constitution’s Dormant Commerce Clause and Equal Protection rights, and claims it is preempted by federal law, further asserting the law unfairly targets out-of-state businesses like CVS while protecting in-state pharmacies that may charge higher prices. This legal challenge highlights a direct threat to CVS's vertically integrated business model, as Arkansas is the first state to implement such a measure. Conversely, Governor Sarah Huckabee Sanders defends the law as a necessary step to curb what she terms "abusive business practices" and "anticompetitive actions" by large PBM corporations. The outcome of this lawsuit carries substantial implications, not only for CVS's operations in Arkansas but also as a potential bellwether for similar regulatory challenges to vertical integration in the U.S. healthcare sector, particularly in rural states already grappling with healthcare access issues.

Key Decisions for Investors

• Investors should closely monitor the progression and outcome of CVS's lawsuit against Arkansas, as it could set a significant precedent for regulatory actions against vertically integrated healthcare models in other states.
• This development warrants a re-evaluation of the regulatory risk exposure for CVS and similar companies, particularly concerning state-level legislative efforts targeting PBMs and integrated pharmacy ownership.
• While the direct financial impact of closing 23 Arkansas stores might be limited for a company of CVS's scale, the greater concern is the potential for contagion to other states, which could materially affect future revenue and operational strategy.
• The heightened legal and regulatory uncertainty introduced by Act 624 and the ensuing lawsuit may exert downward pressure on CVS's valuation until there is greater clarity on the sustainability of its business model against such legislative challenges.